Literature DB >> 17547507

Recent developments in human cytomegalovirus diagnosis.

Gabriele Halwachs-Baumann1.   

Abstract

Since the early 1990s, great efforts have been made in the field of human cytomegalovirus (HCMV) diagnosis. Besides HCMV diagnosis in immunosuppressed patients (solid organ transplant recipients, hematopoietic stem cell transplant patients and AIDS patients), diagnosis in connection with congenital HCMV infection is of great interest. This review focuses on the development and clinical utility of serological assays, as well as on virological tests (molecular and nonmolecular assays). Interpretation of these tests is strongly dependent on the patient group (solid organ transplant recipients and hematopoietic stem cell transplant patients) and whether the tests are used for screening, risk stratification or diagnosis. Furthermore, a better understanding of HCMV infection has led to new approaches in HCMV diagnosis and monitoring. Thus, assays for viral resistance testing and assays for monitoring the HCMV-specific cellular immune response are increasingly important for the guidance of antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547507     DOI: 10.1586/14787210.5.3.427

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  4 in total

1.  Massive splenomegaly due to concurrent primary Epstein-Barr virus and cytomegalovirus infection in a patient on adalimumab.

Authors:  Barathy Rani Ramasamy; Patrick Charles; Douglas Johnson; Albert Frauman
Journal:  BMJ Case Rep       Date:  2017-09-01

2.  HCMV-encoded glycoprotein M (UL100) interacts with Rab11 effector protein FIP4.

Authors:  Magdalena A Krzyzaniak; Michael Mach; William J Britt
Journal:  Traffic       Date:  2009-10       Impact factor: 6.215

Review 3.  Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.

Authors:  Tianrui Yang; Delin Liu; Shiyuan Fang; Wenbin Ma; Yu Wang
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964

4.  Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data.

Authors:  Jessica Leung; Michael J Cannon; Scott D Grosse; Stephanie R Bialek
Journal:  BMC Pediatr       Date:  2013-06-07       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.